Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

With the MiSeq™ i100 Series, Illumina continues to set the highest standards.Advancements in system design, sequencing chemistry, and data analysis deliverthe simplest, fastest benchtop sequencing and ...

Anderson Diagnostics & Labs in Chennai partners with Manipal Academy of Higher Education to launch the MAHE-Anderson Centre of Excellence in Reproductive Genomics. This initiative aims to ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

InnoCare Pharma’s next-generation TRK inhibitor zurletrectinib gets China NMPA approval to treat NTRK fusion-positive tumours: Beijing Saturday, December 13, 2025, 16:30 Hrs [IS ...

Zurletrectinib has been included in the “SPARK Program” by China’s National Medical Products Administration (NMPA), a pilot initiative to encourage the development of pediatric anti-tumor drugs.

Global Nanopore Sequencing Market OverviewThe nanopore sequencing market is projected to grow at a CAGR of around 11% during the forecast period, driven by rising demand for real-time, portable DNA ...

DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical ...

Recent advances in the treatment of non-small cell lung cancer (NSCLC) have led to improved patient outcomes, particularly ...

A central challenge in relapsed/refractory follicular lymphoma is determining a treatment sequence that maximizes current ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can ...